首页> 外文期刊>The lancet oncology >Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.
【24h】

Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.

机译:微血管密度作为非小细胞肺癌的预后因素:对单个患者数据的荟萃分析。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Angiogenesis is a potential prognostic factor that has been investigated in patients with non-small-cell lung carcinoma. However, published studies of the role of angiogenesis as a prognostic factor are inconclusive. We aimed to collect individual patient data to assess microvessel-density counts (ie, a measure of angiogenesis) as a prognostic factor in non-small-cell lung carcinoma. METHODS: We obtained published and unpublished datasets and extracted appropriate data, taking particular care to ensure data quality. Detailed information was obtained for the laboratory methods used by every research centre that generated the data. The outcome of interest was overall survival. We did a meta-analysis to estimate the prognostic role of microvessel density by combining separately estimated hazard ratios (HR) from every study, which were adjusted for tumour stage and age. Analyses were done separately for studies that used the Chalkley method or for those that counted all microvessels. FINDINGS: 17 centres provided data for 3200 patients, 2719 of which were included in the analysis. All but three centres (datasets 9, 10, and 13-367 cases) had already published their findings, and six had updated follow-up information (datasets 1, 2, 3, 6, 7, and 8-1273 cases). For all but three centres (datasets 4, 11, and 13) some data corrections were necessary. For microvessel density counts obtained by the Chalkley method, the HR for death per extra microvessel was 1.05 (95% CI 1.01-1.09, p=0.03) when analysed as a continuous variable. For microvessel density counts obtained by the all vessels method, the HR for death per ten extra microvessels was 1.03 (0.97-1.09, p=0.3) when analysed as a continuous variable. INTERPRETATION: Microvessel density does not seem to be a prognostic factor in patients with non-metastatic surgically treated non-small-cell lung carcinoma. This conclusion contradicts the results of a meta-analysis of published data only. Therefore, the methodology used to assess prognostic factors should be assessed carefully.
机译:背景:血管生成是一种潜在的预后因素,已在非小细胞肺癌患者中进行了研究。但是,关于血管生成作为预后因素的作用的已发表研究尚无定论。我们旨在收集患者的个人数据,以评估微血管密度计数(即血管生成的量度)作为非小细胞肺癌的预后因素。方法:我们获得了已发表和未发表的数据集,并提取了适当的数据,特别注意确保数据质量。获得了每个生成数据的研究中心使用的实验室方法的详细信息。感兴趣的结果是总体存活率。我们进行了荟萃分析,通过结合每项研究的单独估算的危险比(HR)来评估微血管密度的预后作用,并根据肿瘤的阶段和年龄进行了调整。对于使用Chalkley方法的研究或对所有微血管进行计数的研究,都分别进行了分析。结果:17个中心提供了3200名患者的数据,其中2719名被纳入分析。除了三个中心(数据集9、10和13-367的案例)之外,所有中心都已经发表了他们的发现,六个中心更新了随访信息(数据集1、2、3、6、7和8-1273的案例)。对于除三个中心(数据集4、11和13)以外的所有中心,都需要进行一些数据校正。对于通过Chalkley方法获得的微血管密度计数,当作为连续变量进行分析时,每个额外微血管死亡的HR为1.05(95%CI 1.01-1.09,p = 0.03)。对于通过全容器方法获得的微血管密度计数,当作为连续变量进行分析时,每十个额外微血管的死亡HR为1.03(0.97-1.09,p = 0.3)。解释:对于非转移性手术治疗的非小细胞肺癌患者,微血管密度似乎不是预后因素。该结论与仅对已发表数据进行荟萃分析的结果相矛盾。因此,应仔细评估用于评估预后因素的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号